Active
    Mainboard

    Sai Parenteral's Ltd

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Sai Parenteral's Ltd IPO opened on 24 Mar 2026 and closed on 27 Mar 2026, with a price band of ₹372–₹392 per share. The IPO had a lot size of 38 shares, requiring a minimum investment of ₹14,896 per lot at the upper price band. The issue size was ₹408.79 crore, and the shares get listed on 02 Apr 2026.

    Sai Parenteral's Ltd IPO Details

    Listing Date

    02 Apr 2026

    Bid Price

    ₹372 - ₹392

    Lot Size

    38 Shares

    Minimum Investment

    ₹14,896 / Lot

    Issue Size

    ₹408.79 Cr

    Key Dates to Track

        Here are the important dates you need to know in order to participate in this IPO

    tick

    Offer Start Date

    24th Mar

    tick

    Offer End Date

    27th Mar

    tick

    Allotment Date

    30th Mar

    tick

    Refund Initiation

    1st Apr

    tick

    Demat Transfer

    1st Apr

    tick

    Listing Date

    2nd Apr

    About Sai Parenteral's Ltd IPO

    Sai Parenteral’s Ltd., incorporated in 2001, operates in the pharmaceutical formulations segment with activities spanning research, development, and manufacturing. The company functions across two primary segments: branded generic formulations and contract development and manufacturing organisation (CDMO) services for both domestic and international markets. Its product portfolio covers multiple therapeutic areas, including cardiovascular, neuropsychiatry, anti-diabetic, respiratory, antibiotics, gastroenterology, dermatology, and vitamins, minerals, and supplements. These products are offered in various dosage forms such as injectables, tablets, capsules, liquid orals, and ointments, reflecting a diversified formulation presence.
     

    The company supplies its products to a broad customer base that includes government institutions, pharmaceutical companies, hospitals, and distribution networks within India. It commenced export operations in FY 2023 following the acquisition of two internationally accredited facilities in Hyderabad, Telangana, enabling access to regulated and semi-regulated markets such as Australia, New Zealand, Southeast Asia, the Middle East, and Africa. Sai Parenteral’s Ltd. operates five manufacturing facilities across India, including units with GMP, WHO-GMP, and international accreditations. As of December 31, 2025, the company had 298 full-time employees supporting its operations.

    Sai Parenteral's Ltd Shareholding Pattern

      Pre-Issue Post-Issue
    Promoter Group 61.23% 51.16%
    Public Group 38.77% 48.84%

    Sai Parenteral's Ltd IPO Reservation

    QIB Shares Offered 20,85,658 (20%)
    NII (HNI) Shares Offered 15,64,243 (15%)
    Retail Shares Offered 36,49,901 (35%)
    Anchor Investor Shares Offered 31,28,486 (30%)
    Total Shares Offered 1,04,28,288
    Total Shares With Anchor Investor 1,04,28,288

    Sai Parenteral's Ltd IPO Lot Size

    Application Lots Shares Amount
    Retail (Min) 1 38 ₹14,896
    Retail (Max) 13 494 ₹1,93,648
    S HNI (Min) 14 532 ₹2,08,544
    S HNI (Max) 67 2,546 ₹9,98,032
    B HNI (MIN) 68 2,584 ₹10,12,928

    Sai Parenteral's Ltd IPO Anchor Portion Size

    Bid Date March 23, 2026
    Shares Offered 31,28,485
    Anchor Investment Details 122

    Sai Parenteral's Ltd IPO registrar

    Bigshare Services Pvt Ltd
    Phone Number +91 22 6263 8200
    Email Id ipo@bigshareonline.com
    Website www.bigshareonline.com

    Sai Parenteral's Ltd IPO Lead Manager

    1. Arihant Capital Markets Limited

    Sai Parenteral's Ltd Financial Information

    March 31, 2026 March 31, 2025 March 31, 2024
    Net Worth ₹490.77 Cr ₹93.67 Cr ₹74.54 Cr
    Reserves and Surplus ₹468.68 Cr ₹80.36 Cr ₹61.3 Cr
    Total Borrowing ₹319.48 Cr ₹93.95 Cr ₹118.79 Cr

    Sai Parenteral's Ltd IPO Subscription LIVE Status

    Category No. of shares offered No. of shares bid Subscription (Times)
    Qualified Institutional Buyers (QIBs) 21,12,900 36,10,266 1.7087
    Non Institutional Investors (NIIs) 16,22,876 38,31,502 2.3609
    Retail Individual Investors (RIIs) 37,86,710 4,39,204 0.116
    Total 75,22,486 78,80,972 1.05

    Strength of Sai Parenteral's Ltd

    • Diversified generic formulations player with an established track record.
    • Strategically located and accredited Manufacturing Facilities.
    • Strong focus on CDMO business.
    • Well-established sales network in India and overseas.
    • Track record of value-accretive acquisitions.
    • Experienced Promoters and Senior Management with extensive domain knowledge.

    Risks Involved

    • The company's Manufacturing Facilities are concentrated in Hyderabad, Telangana and Ongole, Andhra Pradesh. The company is exposed to risks originating from slowdown or shutdown, economic, regulatory, political and other changes in this region, including natural disasters, which could adversely affect its business, results of operations and financial condition.
    • Out of its diversified product portfolio, approximately 44.78%, 47.64% and 92.03% during the Fiscals 2025, 2024 and 2023, respectively of the company's Net Revenue from Operations was derived from the sale of injectables. Any reduction in demand for these products may adversely affect its business, financial condition, results of operations and cash flows.
    • The company's Manufacturing Facilities are subject to periodic inspections and audits by regulatory authorities and customers. The company may be subject to regulatory action which may damage its reputation, leading to an adverse effect on the company's business, results of operations, financial condition and cash flows.
    • Majority of its key raw material purchases, being APIs, excipients and intermediates, are sourced from a diversified supplier base, and the company does not enter into is not any long-term contractual agreements with them. Any reduction of supplies or discontinuation of supplies from its top suppliers could have a material adverse effect on the company's business, financial condition, results of operations and cash flows. Any fluctuation in prices of its raw materials may have a material adverse effect on the company's business, results of operations, prospects and financial condition.
    • The company's success depends on its ability to successfully develop and commercialize new products in a timely manner. Any failures to do so could adversely affect the company's business, results of operations and financial condition.
    • The company's business is dependent on the sale of products to a limited number of customers for a significant portion of its revenues. The loss of one or more such customers or the deterioration of their financial condition or prospects could adversely affect its business, results of operations and financial condition.
    • The company's international business exposes us to complex management, legal, tax and economic risks, which could adversely affect its business, results of operations and financial condition.
    • There are outstanding legal proceedings involving the Company, Promoters, some of its Directors and, the company's Material Subsidiary.
    • The company plans to expand and/or upgrade its Manufacturing Facilities from the Net Proceeds of the Fresh Issue and will be required to briefly stop operations in Unit I and II till such plans are completed. The company has estimated a period of 6 months for this disruption before both these units can resume operations. The company is also dependent on third-party contractors and specialist agencies who will be executing the proposed expansion and/or upgradation plans.
    • The Indian pharmaceutical market is subject to extensive regulation and its failures to comply with the existing and future regulatory requirements in the pharmaceutical market could adversely affect the company's business, results of operations and financial condition.

    Invest in IPOs with ease

    Sign-in to invest with your demat account, or set up a new demat account for free

    Industry Outlook of Sai Parenterals IPO

    • The Indian pharmaceutical sector ranks third globally in terms of volume and was valued at approximately $62 billion in 2025.

    • Based on available estimates, the industry is projected to expand at a compound annual growth rate (CAGR) of 11.2%, reaching around $146 billion by 2033.

    • The Indian drug formulation market was estimated at nearly $47 billion in 2025.

    • This segment is projected to grow to approximately $109 billion by 2033, reflecting a CAGR of 11.2% during the period.

    • Indian contract development and manufacturing organisations (CDMOs) are expanding their role across the pharmaceutical value chain.

    • Their involvement now spans areas from drug discovery to commercialisation.

    • This expansion is observed across multiple international markets in response to evolving trends in the global pharmaceutical industry.

    • The Indian CDMO segment is expected to sustain its growth trajectory over the next 10 years.

    Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Sai Parenterals IPO.

    Explore Other IPOs

    • Current IPOs
    • Upcoming IPOs
    • Closed IPOs
    • IPO Performance
    • All
    • MainBoard
    • SME
    CORE4 ENGINEERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    23rd Oct 2026 - 10th Oct 2026
    Price Range
    ₹88.0 - 93.0
    IPO Size
    ₹54,82,00,000
    • All
    • MainBoard
    • SME
    Bidding Period
    26th Oct 2026 - 10th Oct 2026
    Price Range
    ₹1585.0 - 1665.0
    IPO Size
    ₹12,00,00,00,000
    BLS Polymers Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹142.0 - 150.0
    IPO Size
    ₹2,55,00,00,128
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹313.0 - 330.0
    IPO Size
    ₹6,67,53,00,352
    Wiscon Industries Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹194.0 - 204.0
    IPO Size
    ₹1,10,00,00,000
    Ajwa Projects Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Oct 2026 - 10th Oct 2026
    Price Range
    ₹203.0 - 203.0
    IPO Size
    ₹0
    Carver Roboweld Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Oct 2026 - 10th Oct 2026
    Price Range
    ₹76.0 - 80.0
    IPO Size
    ₹28,29,00,000
    M K Sons Fine Jewels Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹153.0 - 162.0
    IPO Size
    ₹2,75,39,99,872
    Bidding Period
    29th Oct 2026 - 11th Nov 2026
    Price Range
    ₹78.0 - 82.0
    IPO Size
    ₹1,83,05,99,936
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanced SysTek Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanta Enterprises Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Agilus Diagnostics Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AGS Health Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Airox Technologies Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AITMC Ventures Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Ajay Poly Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    NO ACTIVE IPO HERE
    • All
    • MainBoard
    • SME
    JIO PLATFORMS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹1065.0 - 1119.0
    IPO Size
    ₹3,02,13,00,03,968
    PARAS HEALTHCARE LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹660.0 - 693.0
    IPO Size
    ₹14,49,99,99,744
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹327.0 - 344.0
    IPO Size
    ₹4,75,48,00,128
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹558.0 - 586.0
    IPO Size
    ₹25,33,80,99,712
    SHELLZ INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹170.0 - 179.0
    IPO Size
    ₹59,97,00,032
    TONBO IMAGING INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹665.0 - 700.0
    IPO Size
    ₹8,52,17,99,680
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹143.0 - 151.0
    IPO Size
    ₹50,12,33,00,864
    FUSION CX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Oct 2026 - 10th Oct 2026
    Price Range
    ₹275.0 - 289.0
    IPO Size
    ₹7,02,00,00,256
    Bidding Period
    14th Oct 2026 - 10th Oct 2026
    Price Range
    ₹105.0 - 112.0
    IPO Size
    ₹1,16,04,99,968
    HD FIRE PROTECT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    13th Oct 2026 - 10th Oct 2026
    Price Range
    ₹258.0 - 271.0
    IPO Size
    ₹7,12,12,99,968
    VAIBHAV VYAPAAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    13th Oct 2026 - 10th Oct 2026
    Price Range
    ₹51.0 - 54.0
    IPO Size
    ₹42,10,00,000
    Bidding Period
    5th Oct 2026 - 10th Oct 2026
    Price Range
    ₹77.0 - 82.0
    IPO Size
    ₹34,99,00,032
    PARAMOUNT SYNTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹119.0 - 127.0
    IPO Size
    ₹81,79,00,032
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹186.0 - 196.0
    IPO Size
    ₹1,21,68,99,968
    TNA SOLUTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹66.0 - 70.0
    IPO Size
    ₹37,86,00,000
    SHREE TNB POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Sep 2026 - 10th Oct 2026
    Price Range
    ₹50.0 - 53.0
    IPO Size
    ₹31,80,00,000
    SJP ULTRASONICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹67.0 - 67.0
    IPO Size
    ₹23,45,00,000
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹55.0 - 55.0
    IPO Size
    ₹21,78,00,000
    VISHAL NIRMITI LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹208.0 - 220.0
    IPO Size
    ₹1,78,00,00,000
    EVENTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹112.0 - 118.0
    IPO Size
    ₹38,12,00,000
    • All
    • MainBoard
    • SME
    Issue Prize
    1785.00
    Listing Day Close
    1818.00(1.85%)
    LAPL AUTOMOTIVE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    94.00
    Listing Day Close
    128.29(36.17%)
    Issue Prize
    344.00
    Listing Day Close
    378.20(9.88%)
    Issue Prize
    586.00
    Listing Day Close
    576.35(-1.71%)
    SHELLZ INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    179.00
    Listing Day Close
    170.05(-5.03%)
    TONBO IMAGING INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    700.00
    Listing Day Close
    1133.65(62.00%)
    Issue Prize
    151.00
    Listing Day Close
    138.30(-8.61%)
    FUSION CX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    289.00
    Listing Day Close
    289.75(0.35%)
    HD FIRE PROTECT LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    271.00
    Listing Day Close
    307.20(13.28%)
    Issue Prize
    112.00
    Listing Day Close
    113.70(1.79%)
    VAIBHAV VYAPAAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    54.00
    Listing Day Close
    53.05(-1.85%)
    Issue Prize
    82.00
    Listing Day Close
    76.00(-7.32%)
    PARAMOUNT SYNTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    127.00
    Listing Day Close
    109.25(-14.17%)
    Issue Prize
    196.00
    Listing Day Close
    232.05(18.37%)
    TNA SOLUTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    70.00
    Listing Day Close
    58.80(-15.71%)
    SHREE TNB POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    53.00
    Listing Day Close
    57.00(7.55%)
    SJP ULTRASONICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    67.00
    Listing Day Close
    73.01(8.96%)
    Issue Prize
    55.00
    Listing Day Close
    99.18(80.00%)
    VISHAL NIRMITI LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    220.00
    Listing Day Close
    204.25(-7.27%)
    EVENTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    118.00
    Listing Day Close
    105.45(-11.02%)

    Frequently Asked Questions

    What is Sai Parenteral's Ltd IPO?

    Sai Parenteral's Ltd IPO is a Mainboard IPO of 1,04,28,288 equity shares of a face value of ₹5 aggregating up to ₹408.79 Crores. The issue is priced at ₹372 to ₹392 per share. The minimum order quantity is 38 Shares. The IPO opens on March 24, 2026, and closes on March 27, 2026. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

    When Sai Parenteral's Ltd IPO will open?

    The Sai Parenteral's Ltd IPO opens on March 24, 2026 and closes on March 27, 2026.

    What is the lot size of Sai Parenteral's Ltd?

    Sai Parenteral's Ltd lot size is 38 shares, and the minimum amount required is ₹14,896.

    How to apply for Sai Parenteral's Ltd IPO?

    You can apply in Sai Parenteral's Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

    • Login to Bajaj Broking account App/Website & click on IPO
    • Enter the number of lots and price at which you wish to apply.
    • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
    • You will receive a mandate notification to block funds in your UPI app.
    • Approve the mandate request on your UPI and funds will be blocked.

    When is Sai Parenteral's Ltd IPO allotment?

    The finalization of Basis of Allotment for Sai Parenteral's Ltd IPO will be done on March 30, 2026, and the allotted shares will be credited to your demat account by April 01, 2026.

    When is Sai Parenteral's Ltd IPO listing date?

    The Sai Parenteral's Ltd listing date is April 02, 2026.

    Who is the registrar of Sai Parenteral's Ltd IPO?

    The registrar of Sai Parenteral's Ltd IPO is Bigshare Services Pvt Ltd

    Which company is the book-running lead manager of the IPO?

    Arihant Capital Markets Limited will be the book-running lead manager of this IPO.

    What is the fresh issue of Sai Parenteral's Ltd IPO?

    The fresh issue size is ₹285 Crores equity shares.

    What minimum lot size can retail subscribers subscribe to Sai Parenteral's Ltd?

    Retail investors can subscribe to a minimum of one lot, 38 shares and ₹14,896 amount.

    How can I approve the UPI mandate request for Sai Parenteral's Ltd IPO?

    To apply for Sai Parenteral's Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

    What is the price range of Sai Parenteral's Ltd?

    The price of each Sai Parenteral's Ltd share will be ranging in between ₹372 to ₹392 per share.

    What is the cut-off time for the UPI mandate for Sai Parenteral's Ltd IPO?

    The cut-off time for the UPI mandate confirmation is 5:00 PM, March 27, 2026.

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |